CBL

gene product
c-Cbl, CBL2, RNF55
This gene is a proto-oncogene that encodes a RING finger E3 ubiquitin ligase. The encoded protein is one of the enzymes required for targeting substrates for degradation by the proteasome. This protein mediates the transfer of ubiquitin from ubiquitin conjugating enzymes (E2) to specific substrates. This protein also contains an N-terminal phosphotyrosine binding domain that allows it to interact with numerous tyrosine-phosphorylated substrates and target them for proteasome degradation. As such it functions as a negative regulator of many signal transduction pathways. This gene has been found to be mutated or translocated in many cancers including acute myeloid leukaemia. Mutations in this gene are also the cause of Noonan syndrome-like disorder. [provided by RefSeq, Mar 2012]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Reference

Provider

Host

Reactivity

Antibody type

  or   Clear
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
205 antibodies from 22 providers.

Antibody properties

Applications

or Cancel
AntibodyRefsTypeWBELIFIPIHFC
Acris Antibodies GmbH
15 antibodies
Thermo Fisher Scientific Pierce
6 antibodies
GeneTex
12 antibodies
Abnova Corporation
17 antibodies
Novus Biologicals
26 antibodies
Atlas Antibodies
1 antibody
Santa Cruz Biotechnology
1 antibody
antibodies-online
50 antibodies
Cell Signaling Technology, Inc
6 antibodies
Aviva Systems Biology
4 antibodies
Bethyl Laboratories, Inc.
2 antibodies
Epitomics
8 antibodies
ProSci
1 antibody
Creative Biomart
20 antibodies
EMD Millipore
3 antibodies
LifeSpan BioSciences, Inc.
17 antibodies
BioLegend
1 antibody
Boster Immunoleader Biotechnology
1 antibody
Abiocode, Inc.
4 antibodies
Everest Biotech
1 antibody
Sigma-Aldrich
5 antibodies
GenWay
4 antibodies